首页> 美国卫生研究院文献>Chemical Science >Stereoselective synthesis of macrocyclic peptides via a dual olefin metathesis and ethenolysis approach
【2h】

Stereoselective synthesis of macrocyclic peptides via a dual olefin metathesis and ethenolysis approach

机译:通过双烯烃复分解和乙烯分解方法立体选择性合成大环肽

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Macrocyclic compounds occupy an important chemical space between small molecules and biologics and are prevalent in many natural products and pharmaceuticals. The growing interest in macrocycles has been fueled, in part, by the design of novel synthetic methods to these compounds. One appealing strategy is ring-closing metathesis (RCM) that seeks to construct macrocycles from acyclic diene precursors using defined transition-metal alkylidene catalysts. Despite its broad utility, RCM generally gives rise to a mixture of E- and Z-olefin isomers that can hinder efforts for the large-scale production and isolation of such complex molecules. To address this issue, we aimed to develop methods that can selectively enrich macrocycles in E- or Z-olefin isomers using an RCM/ethenolysis strategy. The utility of this methodology was demonstrated in the stereoselective formation of macrocyclic peptides, a class of compounds that have gained prominence as therapeutics in drug discovery. Herein, we report an assessment of various factors that promote catalyst-directed RCM and ethenolysis on a variety of peptide substrates by varying the olefin type, peptide sequence, and placement of the olefin in macrocycle formation. These methods allow for control over olefin geometry in peptides, facilitating their isolation and characterization. The studies outlined in this report seek to expand the scope of stereoselective olefin metathesis in general RCM.
机译:大环化合物在小分子和生物制剂之间占据重要的化学空间,并在许多天然产品和药物中普遍存在。人们对大环化合物的兴趣日益增长,部分原因是通过设计这些化合物的新颖合成方法来进行的。一种有吸引力的策略是闭环复分解(RCM),其试图使用确定的过渡金属亚烷基催化剂由无环二烯前体构建大环。尽管RCM具有广泛的用途,但通常会产生E-和Z-烯烃异构体的混合物,这可能会阻碍大规模生产和分离此类复杂分子的努力。为了解决这个问题,我们旨在开发可以使用RCM /乙烯分解策略选择性富集E-或Z-烯烃异构体中大环化合物的方法。这种方法的实用性在大环肽的立体选择性形成中得到了证明,大环肽是一类在药物发现中作为治疗剂而突出的化合物。本文中,我们报告了通过改变烯烃类型,肽序列和烯烃在大环形成中的位置,促进各种肽底物上催化剂导向的RCM和乙烯分解的各种因素的评估。这些方法允许控制肽中的烯烃几何形状,从而有助于其分离和表征。本报告概述的研究旨在扩大常规RCM中立体选择性烯烃复分解的范围。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号